Global Human Coagulation Factor VIII Market by Manufacturers, Regions, Type and Application, Forecast to 2021

According to Custom Market Inights analysis, The global human coagulation factor viii market is expected to register a healthy CAGR during the period from 2016 to 2025. This report studies the human coagulation factor viii status and outlook of global and major regions, from angles of manufacturers, regions, product types and end industries; this report analyzes the top manufacturers in global and major regions, and splits the human coagulation factor viii by product type and applications/end industries.

Human Coagulation Factor VIII is an essential blood-clotting protein, also known as anti-hemophilic factor (AHF). In humans, factor VIII is encoded by the F8 gene, defects in this gene results in hemophilia A.

Scope of the Report:

This report focuses on the Human Coagulation Factor VIII in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

Baxter

Bayer

CSL

Pfizer

Grifols

Biogen

Octapharma

NovoNordisk

Greencross

Kedrion

BPL

Hualan Bio

RAAS

Market Segment by Regions, regional analysis covers

North America (USA, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America, Middle East and Africa

Market Segment by Type, covers

Recombinant Factor VIII

Plasma-derived Factor VIII

Market Segment by Applications, can be divided into

Hemophilia A

Spontanous / Trauma

Surgical

Other

There are 13 Chapters to deeply display the global Human Coagulation Factor VIII market.

Chapter 1, to describe Human Coagulation Factor VIII Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Human Coagulation Factor VIII, with sales, revenue, and price of Human Coagulation Factor VIII, in 2015 and 2016;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2015 and 2016;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Human Coagulation Factor VIII, for each region, from 2011 to 2016;

Chapter 5, 6, 7 and 8, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 9 and 10, to show the market by type and application, with sales market share and growth rate by type, application, from 2011 to 2016;

Chapter 11, Human Coagulation Factor VIII market forecast, by regions, type and application, with sales and revenue, from 2016 to 2021;

Chapter 12 and 13, to describe Human Coagulation Factor VIII sales channel, distributors, traders, dealers, appendix and data source.

Table of Contents

Global Human Coagulation Factor VIII Market by Manufacturers, Regions, Type and Application, Forecast to 2021

1 Market Overview

1.1 Human Coagulation Factor VIII Introduction

1.2 Market Analysis by Type

1.2.1 Recombinant Factor VIII

1.2.2 Plasma-derived Factor VIII

1.3 Market Analysis by Applications

1.3.1 Hemophilia A

1.3.2 Spontanous / Trauma

1.3.3 Surgical

1.4 Market Analysis by Regions

1.4.1 North America (USA, Canada and Mexico)

1.4.1.1 USA

1.4.1.2 Canada

1.4.1.3 Mexico

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany

1.4.2.2 France

1.4.2.3 UK

1.4.2.4 Russia

1.4.2.5 Italy

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China

1.4.3.2 Japan

1.4.3.3 Korea

1.4.3.4 India

1.4.3.5 Southeast Asia

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil

1.4.4.2 Egypt

1.4.4.3 Saudi Arabia

1.4.4.4 South Africa

1.4.4.5 Nigeria

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Baxter

2.1.1 Business Overview

2.1.2 Human Coagulation Factor VIII Type and Applications

2.1.2.1 Type 1

2.1.2.2 Type 2

2.1.3 Baxter Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share

2.2 Bayer

2.2.1 Business Overview

2.2.2 Human Coagulation Factor VIII Type and Applications

2.2.2.1 Type 1

2.2.2.2 Type 2

2.2.3 Bayer Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share

2.3 CSL

2.3.1 Business Overview

2.3.2 Human Coagulation Factor VIII Type and Applications

2.3.2.1 Type 1

2.3.2.2 Type 2

2.3.3 CSL Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share

2.4 Pfizer

2.4.1 Business Overview

2.4.2 Human Coagulation Factor VIII Type and Applications

2.4.2.1 Type 1

2.4.2.2 Type 2

2.4.3 Pfizer Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share

2.5 Grifols

2.5.1 Business Overview

2.5.2 Human Coagulation Factor VIII Type and Applications

2.5.2.1 Type 1

2.5.2.2 Type 2

2.5.3 Grifols Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share

2.6 Biogen

2.6.1 Business Overview

2.6.2 Human Coagulation Factor VIII Type and Applications

2.6.2.1 Type 1

2.6.2.2 Type 2

2.6.3 Biogen Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share

2.7 Octapharma

2.7.1 Business Overview

2.7.2 Human Coagulation Factor VIII Type and Applications

2.7.2.1 Type 1

2.7.2.2 Type 2

2.7.3 Octapharma Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share

2.8 NovoNordisk

2.8.1 Business Overview

2.8.2 Human Coagulation Factor VIII Type and Applications

2.8.2.1 Type 1

2.8.2.2 Type 2

2.8.3 NovoNordisk Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share

2.9 Greencross

2.9.1 Business Overview

2.9.2 Human Coagulation Factor VIII Type and Applications

2.9.2.1 Type 1

2.9.2.2 Type 2

2.9.3 Greencross Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share

2.10 Kedrion

2.10.1 Business Overview

2.10.2 Human Coagulation Factor VIII Type and Applications

2.10.2.1 Type 1

2.10.2.2 Type 2

2.10.3 Kedrion Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share

2.11 BPL

2.11.1 Business Overview

2.11.2 Human Coagulation Factor VIII Type and Applications

2.11.2.1 Type 1

2.11.2.2 Type 2

2.11.3 BPL Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share

2.12 Hualan Bio

2.12.1 Business Overview

2.12.2 Human Coagulation Factor VIII Type and Applications

2.12.2.1 Type 1

2.12.2.2 Type 2

2.12.3 Hualan Bio Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share

2.13 RAAS

2.13.1 Business Overview

2.13.2 Human Coagulation Factor VIII Type and Applications

2.13.2.1 Type 1

2.13.2.2 Type 2

2.13.3 RAAS Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share

3 Global Human Coagulation Factor VIII Market Competition, by Manufacturer

3.1 Global Human Coagulation Factor VIII Sales and Market Share by Manufacturer

3.2 Global Human Coagulation Factor VIII Revenue and Market Share by Manufacturer

3.3 Market Concentration Rate

3.3.1 Top 3 Human Coagulation Factor VIII Manufacturer Market Share

3.3.2 Top 6 Human Coagulation Factor VIII Manufacturer Market Share

3.4 Market Competition Trend

4 Global Human Coagulation Factor VIII Market Analysis by Regions

4.1 Global Human Coagulation Factor VIII Sales, Revenue and Market Share by Regions

4.1.1 Global Human Coagulation Factor VIII Sales by Regions (2011-2016)

4.1.2 Global Human Coagulation Factor VIII Revenue by Regions (2011-2016)

4.2 North America Human Coagulation Factor VIII Sales and Growth (2011-2016)

4.3 Europe Human Coagulation Factor VIII Sales and Growth (2011-2016)

4.4 Asia-Pacific Human Coagulation Factor VIII Sales and Growth (2011-2016)

4.5 South America Human Coagulation Factor VIII Sales and Growth (2011-2016)

4.6 Middle East and Africa Human Coagulation Factor VIII Sales and Growth (2011-2016)

5 North America Human Coagulation Factor VIII by Countries

5.1 North America Human Coagulation Factor VIII Sales, Revenue and Market Share by Countries

5.1.1 North America Human Coagulation Factor VIII Sales by Countries (2011-2016)

5.1.2 North America Human Coagulation Factor VIII Revenue by Countries (2011-2016)

5.2 USA Human Coagulation Factor VIII Sales and Growth (2011-2016)

5.3 Canada Human Coagulation Factor VIII Sales and Growth (2011-2016)

5.4 Mexico Human Coagulation Factor VIII Sales and Growth (2011-2016)

6 Europe Human Coagulation Factor VIII by Countries

6.1 Europe Human Coagulation Factor VIII Sales, Revenue and Market Share by Countries

6.1.1 Europe Human Coagulation Factor VIII Sales by Countries (2011-2016)

6.1.2 Europe Human Coagulation Factor VIII Revenue by Countries (2011-2016)

6.2 Germany Human Coagulation Factor VIII Sales and Growth (2011-2016)

6.3 UK Human Coagulation Factor VIII Sales and Growth (2011-2016)

6.4 France Human Coagulation Factor VIII Sales and Growth (2011-2016)

6.5 Russia Human Coagulation Factor VIII Sales and Growth (2011-2016)

6.6 Italy Human Coagulation Factor VIII Sales and Growth (2011-2016)

7 Asia-Pacific Human Coagulation Factor VIII by Countries

7.1 Asia-Pacific Human Coagulation Factor VIII Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Human Coagulation Factor VIII Sales by Countries (2011-2016)

7.1.2 Asia-Pacific Human Coagulation Factor VIII Revenue by Countries (2011-2016)

7.2 China Human Coagulation Factor VIII Sales and Growth (2011-2016)

7.3 Japan Human Coagulation Factor VIII Sales and Growth (2011-2016)

7.4 Korea Human Coagulation Factor VIII Sales and Growth (2011-2016)

7.5 India Human Coagulation Factor VIII Sales and Growth (2011-2016)

7.6 Southeast Asia Human Coagulation Factor VIII Sales and Growth (2011-2016)

8 South America, Middle East and Africa Human Coagulation Factor VIII by Countries

8.1 South America, Middle East and Africa Human Coagulation Factor VIII Sales, Revenue and Market Share by Countries

8.1.1 South America, Middle East and Africa Human Coagulation Factor VIII Sales by Countries (2011-2016)

8.1.2 South America, Middle East and Africa Human Coagulation Factor VIII Revenue by Countries (2011-2016)

8.2 Brazil Human Coagulation Factor VIII Sales and Growth (2011-2016)

8.3 Saudi Arabia Human Coagulation Factor VIII Sales and Growth (2011-2016)

8.4 Egypt Human Coagulation Factor VIII Sales and Growth (2011-2016)

8.5 Nigeria Human Coagulation Factor VIII Sales and Growth (2011-2016)

8.6 South Africa Human Coagulation Factor VIII Sales and Growth (2011-2016)

9 Human Coagulation Factor VIII Market Segment by Type

9.1 Global Human Coagulation Factor VIII Sales, Revenue and Market Share by Type (2011-2016)

9.1.1 Global Human Coagulation Factor VIII Sales and Market Share by Type (2011-2016)

9.1.2 Global Human Coagulation Factor VIII Revenue and Market Share by Type (2011-2016)

9.2 Recombinant Factor VIII Sales Growth and Price

9.2.1 Global Recombinant Factor VIII Sales Growth (2011-2016)

9.2.2 Global Recombinant Factor VIII Price (2011-2016)

9.3 Plasma-derived Factor VIII Sales Growth and Price

9.3.1 Global Plasma-derived Factor VIII Sales Growth (2011-2016)

9.3.2 Global Plasma-derived Factor VIII Price (2011-2016)

9.4 Sales Growth and Price

9.4.1 Global Sales Growth (2011-2016)

9.4.2 Global Price (2011-2016)

10 Human Coagulation Factor VIII Market Segment by Application

10.1 Global Human Coagulation Factor VIII Sales Market Share by Application (2011-2016)

10.2 Hemophilia A Sales Growth (2011-2016)

10.3 Spontanous / Trauma Sales Growth (2011-2016)

10.4 Surgical Sales Growth (2011-2016)

10.5 Other Sales Growth (2011-2016)

11 Human Coagulation Factor VIII Market Forecast (2016-2021)

11.1 Global Human Coagulation Factor VIII Sales, Revenue and Growth Rate (2016-2021)

11.2 Human Coagulation Factor VIII Market Forecast by Regions (2016-2021)

11.3 Human Coagulation Factor VIII Market Forecast by Type (2016-2021)

11.4 Human Coagulation Factor VIII Market Forecast by Application (2016-2021)

12 Sales Channel, Distributors, Traders and Dealers

12.1 Sales Channel

12.1.1 Direct Marketing

12.1.2 Indirect Marketing

12.1.3 Marketing Channel Future Trend

12.2 Distributors, Traders and Dealers

13 Appendix

13.1 Methodology

13.2 Analyst Introduction

13.3 Data Source

Name: (required)

Email: (required)

Phone: (required)

Company: (required)

Designation: (required)

Country: (required)

How can we help you?:

Type the pieces of text below (required)
captcha



Name: (required)

Email: (required)

Phone: (required)

Company: (required)

Designation: (required)

Country: (required)

How can we help you?:

Type the pieces of text below (required)
captcha



Jacob Thomass